Evaluation of a directly observed six months fully intermittent treatment regimen for tuberculosis in patients suspected of poor compliance.
BACKGROUND
Although a priority for tuberculosis control is to achieve the maximum cure rate, compliance with chemotherapy in specific high risk groups (homeless, intravenous drug abusers, chronic alcoholics) is usually poor.


METHODS
From January 1990 to December 1994 102 patients with tuberculosis (96 pulmonary, six extrapulmonary) who were poorly compliant with treatment were treated with a six month fully intermittent (twice weekly) directly observed regimen. They comprised 71 homeless subjects, 50 chronic alcoholics, 23 intravenous drug abusers, nine infected with HIV, and 11 who had previously abandoned a daily antituberculosis regimen; 53 had more than one of these risk factors. Treatment included isoniazid and rifampicin for six months and pyrazinamide during the first two months. Patients who failed to take their medication on two consecutive occasions were actively sought by telephone or by personal search.


RESULTS
After two months of treatment 95 of the 102 patients had taken their medication regularly and 90 of them had negative cultures. Four of the remaining patients had negative cultures after three months. At the end of the six months 87 patients had completed treatment and were considered cured. Only 15 patients abandoned the treatment (13 of whom had more than one risk factor). Only three relapses occurred in the 102 patients at one year follow up and in the 88 patients followed for two years. Two patients required a change of treatment due to major side effects. Although intravenous drug abuse was the only predictor of non-compliance in the multivariate analysis, if the available variables in the second month of treatment were analysed, current poor compliance and abandonment of treatment in the past were found to be significantly associated with non-compliance.


CONCLUSIONS
This study shows the efficacy of this intermittent regimen and the effectiveness of a directly observed treatment programme.
Caminero
J A
JA
Hospital Ntra. Sra. del Pino, Universidad de Las Palmas de Gran Canaria, Spain.
Pavón
J M
JM
Rodríguez de Castro
F
F
Díaz
F
F
Julià
G
G
Caylá
J A
JA
Cabrera
P
P
D000293:Adolescent; D000328:Adult; D000437:Alcoholism / Q000150:complications; D000995:Antitubercular Agents / Q000008:administration & dosage* / Q000627:therapeutic use; D004334:Drug Administration Schedule; D005260:Female; D006703:Ill-Housed Persons; D006801:Humans; D008297:Male; D008875:Middle Aged; D010349:Patient Compliance; D012307:Risk Factors; D015819:Substance Abuse, Intravenous / Q000150:complications; D016312:Treatment Refusal; D014376:Tuberculosis / Q000150:complications / Q000188:drug therapy* / Q000523:psychology
D000995:Antitubercular Agents